BIOVAIL TO PROMOTE NOVARTIS' LESCOL FRANCHISE IN CANADA

A A

Biovail Corporation today announced that Biovail Pharmaceuticals Canada (BPC), the Company's Canadian sales and marketing division, has entered into an agreement with Novartis Pharmaceuticals Canada Inc., a wholly owned subsidiary of Novartis AG, to market and promote cholesterol medicines Lescol, fluvastatin sodium capsules, and once-daily Lescol XL, fluvastatin sodium extended-release tablets, to Canadian specialists and primary-care physicians.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060519005116&newsLang=en)